These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8369487)

  • 1. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
    Maldonado R; Derrien M; Noble F; Roques BP
    Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
    Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
    Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
    Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
    Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
    Rezayat M; Oreizi S; Zarrindast MR
    Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management.
    Nieto MM; Wilson J; Walker J; Benavides J; Fournié-Zaluski MC; Roques BP; Noble F
    Neuropharmacology; 2001 Sep; 41(4):496-506. PubMed ID: 11543770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
    Zhou Y; Sun YH; Han JS
    Sheng Li Xue Bao; 1993 Jun; 45(3):255-61. PubMed ID: 8235725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
    Maldonado R; Valverde O; Ducos B; Blommaert AG; Fournie-Zaluski MC; Roques BP
    Br J Pharmacol; 1995 Mar; 114(5):1031-9. PubMed ID: 7780637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M; Noble F; Maldonado R; Roques BP
    Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
    Dauge V; Corringer PJ; Roques BP
    Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.
    Noble F; Derrien M; Roques BP
    Br J Pharmacol; 1993 Aug; 109(4):1064-70. PubMed ID: 8401918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
    Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
    Ayres EA; Parkhurst DN; Fang S; Kramer TH; Hruby VJ; Burks TF
    Proc West Pharmacol Soc; 1991; 34():477-84. PubMed ID: 1788334
    [No Abstract]   [Full Text] [Related]  

  • 18. Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
    Smadja C; Maldonado R; Turcaud S; Fournie-Zaluski MC; Roques BP
    Psychopharmacology (Berl); 1995 Aug; 120(4):400-8. PubMed ID: 8539320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
    Lavigne GJ; Millington WR; Mueller GP
    Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    Zhou Y; Sun YH; Zhang ZW; Han JS
    Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.